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The ribosome inactivating proteins RIPs from plants possess RNA N-glycosidase activity that
depurinates the maj or rRNA, thus damaging ribosome in an irreversible manner and arresting
protein synthesis. RIPs occur in fungi, bacteria and plants and are abundant in angiosperms,
where they appear to have defensive role1 . RIPs are presently classified as rRNA N-glycosidase
in the enzyme nomenclature EC 3.2.2.22 and do exhibit other enzymatic activities such as
ribonuclease and deoxy - ribonuclease activities. RIPs have been shown to manifest anti-viral2 , 
anti-tumor3 , and anti-microbial activities. The RIPs have attracted a great deal of attention
because of their potential use in medical research and development. Here, we describe isolation
of a novel protein from Momordica sp that has been verified by SDS-PAGE and mass
spectrometry to contain only single chain Type-1 ribosome inactivating proteins RIPs. The
novel protein is further characterized to validate its therapeutic potential. 
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